This trial is enrolling individuals with acute spinal cord injury (up to 7 days post injury) to test the safety and efficacy of the administration of umbilical cord blood cells. If included, participants will receive either: 4 infusions of allogenic cord blood cells samples within a 1-week interval; or 4 infusions of sterile saline (control). Final testing of safety and neurological outcomes will be performed after 12 months.
Type
Details
- participants will receive 4 infusions of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells samples with a 1-week interval. - Final testing of safety and neurological outcomes will be performed after 12 months.
Main benefits
General health
Additional benefits
Arm/hand function
Bladder health/function
Mental health and psychosocial factors
Pain
Sensory function
Spasticity
Standing/walking/mobility
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more